Results 101 to 110 of about 14,407 (150)

Characteristics of pediatric-onset anti-contactin1 antibody-associated autoimmune nodopathies with concomitant membranous nephropathy. [PDF]

BMC Pediatr
Guan Q, Xie Y, He Y, Qiu L, Liu Y.
europepmc   +1 more source

Prospective Cohort Study of Obinutuzumab in Rituximab-Resistant Primary Membranous Nephropathy. [PDF]

Kidney Int Rep
Trillini M, Portalupi V, Gennarini A, Surdi L, Currado A, Marasà M, Podestà MA, Villa A, Peracchi T, Fidone D, Rubis N, Diadei O, Guarinoni C, Casiraghi F, Todeschini M, Cugini D, Carrara F, Martinetti D, Rizzo P, Remuzzi G, Ruggenenti P.   +20 more
europepmc   +1 more source

Discovery of non-invasive biomarkers for accurate detection of membranous nephropathy. [PDF]

Sci Rep
Li Y, Kim JH, Kang J, Han SS, Cho JY.
europepmc   +1 more source

Concurrent anti-glomerular basement membrane disease and membranous nephropathy: a case report. [PDF]

Front Med (Lausanne)
Li LL, Niu PY, Li N, Zhang XL, Cao HX.
europepmc   +1 more source

Targeting CD20 in Primary Membranous Nephropathy Serologically and Histologically Negative for PLA2R: Is Obinutuzumab Superior to Rituximab? [PDF]

Drug Des Devel Ther
Cao H, Feng Y, Li X, Ke B, Gong L.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Segmental membranous nephropathy

Clinical and Experimental Nephrology, 2021
Most cases of membranous nephropathy (MGN) present with global and diffuse distribution of subepithelial deposits. However, segmental MGN, in which there is focal or diffuse segmental subepithelial deposits, are occasionally encountered. The clinical and pathologic significance of segmental MGN is not well understood and thought to be more likely due ...
Hae Yoon Grace Choung, Bruce Goldman
openaire   +2 more sources